24
Jul
Swiss skincare company Galderma boosts 2025 sales forecast, shares surge
0
Galderma Raises 2025 Outlook Amid Sales Growth ZURICH (Reuters) – Swiss skincare company Galderma increased its 2025 outlook after a 12.2% net sales growth in the first half of the year, with strong performance in the U.S. and international markets. The company now anticipates net sales growth of 12% to 14% for the year at constant currency, up from a previous estimate of 10-12%. It maintains a core EBITDA margin guidance of around 23%. Galderma’s shares, which began trading on the Swiss stock exchange in March 2024, have surged by... Read More




